Skip to main content

Advertisement

Log in

Evaluation of Local CYP17A1 and CYP19A1 Expression Levels as Prognostic Factors in Postmenopausal Invasive Ductal Breast Cancer Cases

  • Original Article
  • Published:
Biochemical Genetics Aims and scope Submit manuscript

Abstract

There is growing attention focused on local estrogen production in the breast tissue and its possible role in breast cancer initiation and progression. Understanding the underlying mechanisms for estrogen synthesis and the microenvironment consisting of tumor and its surrounding adipose tissue might open new avenues in breast cancer prevention, prognosis and treatment. In order to obtain insight, we compared peritumoral and tumor tissue expressions of CYP17A1 and CYP19A1 genes, which play an important role in estrogen biosynthesis. The paired tissue samples of 20 postmenopausal ER+/PR+ patients diagnosed with invasive ductal breast cancer were studied. In addition, 12 breast tissue samples obtained from premenopausal women without a history of breast cancer were also investigated as representative of normal conditions. Peritumoral adipose tissues expressed CYP19A1 approximately threefold higher than tumor itself (p = 0.001). A nonsignificant trend toward low expression of CYP17A1 was observed in peritumoral compared to tumor tissue (p = 0.687). Clinicopathological parameters and patient characteristics which are accepted as risk factors for breast cancer were also associated with individual and combined expressions of CYP17A1 and CYP19A1. This study offers that evaluation of CYP17A1 and CYP19A1 local expression levels might be useful for deciding on personalized treatment approaches and more accurate diagnosis, when evaluated together with several clinicopathological and disease risk factors. Considering the key role of these CYPs in estrogen synthesis, determining their expression levels may be useful as a postdiagnostic marker and for choosing the right treatment method in addition to the conventional approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Abul-Hajj YJ, Iverson R, Kiang DT (1979) Metabolism of pregnenolone by human breast cancer. Evidence for 17 alpha-hydroxylase and 17,20-lyase. Steroids 34:817–827

    Article  CAS  PubMed  Google Scholar 

  • Aiginger P, Kolbe H, Kühböck J, Spona J, Geyer G (1981) The endocrinology of testicular germinal cell tumors. Acta Endocrinol (Copenh) 97:419–426

    CAS  Google Scholar 

  • Blankenstein MA, van de Ven J, Maitimu-Smeele I, Donker GH, de Jong PC, Daroszewski J, Szymczak J, Milewicz A, Thijssen JH (1999) Intratumoral levels of estrogens in breast cancer. J Steroid Biochem Mol Biol 69:293–297

    Article  CAS  PubMed  Google Scholar 

  • Britt K, Ashworth A, Smalley M (2007) Pregnancy and the risk of breast cancer. Endocr Relat Cancer 14:907–933

    Article  CAS  PubMed  Google Scholar 

  • Bulun SE, Simpson ER (2008) Aromatase expression in women’s cancers. Adv Exp Med Biol 630:112–132

    Article  CAS  PubMed  Google Scholar 

  • Bulun SE, Noble LS, Takayama K, Michael MD, Agarwal V, Fisher C, Zhao Y, Hinshelwood MM, Ito Y, Simpson ER (1997) Endocrine disorders associated with inappropriately high aromatase expression. J Steroid Biochem Mol Biol 61:133–139

    Article  CAS  PubMed  Google Scholar 

  • Carruba G (2009) Aromatase in nontumoral and malignant human liver tissues and cells. Ann NY Acad Sci 1155:187–193

    Article  CAS  PubMed  Google Scholar 

  • Chen Y, Gammon MD, Teitelbaum SL, Britton JA, Terry MB, Shantakumar S, Eng SM, Wang Q, Gurvich I, Neugut AI, Santella RM, Ahsan H (2008) Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project. Carcinogenesis 29:766–777

    Article  CAS  PubMed  Google Scholar 

  • Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344:276–285

    Article  CAS  PubMed  Google Scholar 

  • Donegan WL (1997) Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 47:28–51

    Article  CAS  PubMed  Google Scholar 

  • Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE (1997) A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 57:1063–1065

    CAS  PubMed  Google Scholar 

  • Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97:1652–1662

    Article  CAS  PubMed  Google Scholar 

  • Geisler J (2003) Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators. J Steroid Biochem Mol Biol 86:245–253

    Article  CAS  PubMed  Google Scholar 

  • Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, Kelsey KT, Hunter DJ (1999) The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 59:1015–1020

    CAS  PubMed  Google Scholar 

  • Hammond ME, Hayes DF, Wolff AC, Mangu PB, Temin S (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract 6:195–197

    Article  PubMed  PubMed Central  Google Scholar 

  • Helzlsouer KJ, Huang HY, Strickland PT, Hoffman S, Alberg AJ, Comstock GW, Bell DA (1998) Association between CYP17 polymorphisms and the development of breast cancer. Cancer Epidemiol Biomarkers Prev 7:945–949

    CAS  PubMed  Google Scholar 

  • Henderson BE, Feigelson HS (2000) Hormonal carcinogenesis. Carcinogenesis 21:427–433

    Article  CAS  PubMed  Google Scholar 

  • Hortobagyi GN, Buzdar AU (1995) Current status of adjuvant systemic therapy for primary breast cancer: progress and controversy. CA Cancer J Clin 45:199–226

    Article  CAS  PubMed  Google Scholar 

  • Jongen VH, Hollema H, Van Der Zee AG, Heineman MJ (2006) Aromatase in the context of breast and endometrial cancer. A review. Minerva Endocrinol 31:47–60

    CAS  PubMed  Google Scholar 

  • Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174

    Article  CAS  PubMed  Google Scholar 

  • Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R, Martin L, Boyd N (2005) The association of measured breast tissue characteristics with mammographic density, other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 14:343–349

    Article  PubMed  Google Scholar 

  • Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408

    Article  CAS  PubMed  Google Scholar 

  • Meng L, Zhou J, Hironobu S, Suzuki T, Zeitoun K, Bulun SE (2001) TNFalpha and IL-11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively downregulating C/EBPalpha and PPARgamma: mechanism of desmoplastic reaction. Cancer Res 61:2250–2255

    CAS  PubMed  Google Scholar 

  • Miyoshi Y, Ando A, Ooka M, Shiba E, Taguchi T, Tamaki Y, Noguchi S (2003) Association of CYP17 genetic polymorphism with intra-tumoral estradiol concentrations but not with CYP17 messenger RNA levels in breast cancer tissue. Cancer Lett 195:81–86

    Article  CAS  PubMed  Google Scholar 

  • Pattarozzi A, Gatti M, Barbieri F, Würth R, Porcile C, Lunardi G, Ratto A, Favoni R, Bajetto A, Ferrari A, Florio T (2008) 17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment. Mol Pharmacol 73:191–202

    Article  CAS  PubMed  Google Scholar 

  • Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17–35

    CAS  PubMed  Google Scholar 

  • Purdie CA, Quinlan P, Jordan LB, Ashfield A, Ogston S, Dewar JA, Thompson AM (2014) Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study. Br J Cancer 110:565–572

    Article  CAS  PubMed  Google Scholar 

  • Reed MJ, Aherne GW, Ghilchik MW, Patel S, Chakraborty J (1991) Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues. Int J Cancer 49:562–565

    Article  CAS  PubMed  Google Scholar 

  • Russo J, Moral R, Balogh GA, Mailo D, Russo IH (2005) The protective role of pregnancy in breast cancer. Breast Cancer Res 7:131–142

    Article  PubMed  PubMed Central  Google Scholar 

  • Santen RJ, Santner SJ, Pauley RJ, Tait L, Kaseta J, Demers LM, Hamilton C, Yue W, Wang JP (1997) Estrogen production via the aromatase enzyme in breast carcinoma: which cell type is responsible? J Steroid Biochem Mol Biol 61:267–271

    Article  CAS  PubMed  Google Scholar 

  • Sasano H, Miki Y, Nagasaki S, Suzuki T (2009) In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology. Pathol Int 59:777–789

    Article  CAS  PubMed  Google Scholar 

  • Setiawan VW, Schumacher FR, Haiman CA, Stram DO, Albanes D, Altshuler D, Berglund G, Buring J, Calle EE, Clavel-Chapelon F, Cox DG, Gaziano JM, Hankinson SE, Hayes RB, Henderson BE, Hirschhorn J, Hoover R, Hunter DJ, Kaaks R, Kolonel LN, Kraft P, Ma J, Le Marchand L, Linseisen J, Lund E, Navarro C, Overvad K, Palli D, Peeters PH, Pike MC, Riboli E, Stampfer MJ, Thun MJ, Travis R, Trichopoulos D, Yeager M, Ziegler RG, Spencer Feigelson H, Chanock SJ (2007) CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 16:2237–2246

    Article  CAS  PubMed  Google Scholar 

  • Sidoni A, Cavaliere A, Bellezza G, Scheibel M, Bucciarelli E (2003) Breast cancer in young women: clinicopathological features and biological specificity. Breast 12:247–250

    Article  CAS  PubMed  Google Scholar 

  • Simpson ER, Brown KA (2013) Obesity and breast cancer: role of inflammation and aromatase. J Mol Endocrinol 51:T51–T59

    Article  CAS  PubMed  Google Scholar 

  • Simpson ER, Misso M, Hewitt KN, Hill RA, Boon WC, Jones ME, Kovacic A, Zhou J, Clyne CD (2005) Estrogen—the good, the bad, and the unexpected. Endocr Rev 26:322–330

    Article  CAS  PubMed  Google Scholar 

  • Surekha D, Sailaja K, Rao DN, Padma T, Raghunadharao D et al (2014) Association of CYP19 polymorphisms with breast cancer risk: a case-control study. J Nat Sci Biol Med 5:250–254

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tüzüner BM, Oztürk T, Kisakesen HI, Ilvan S, Zerrin C, Oztürk O, Isbir T (2010) CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility. In Vivo 24:71–74

    PubMed  Google Scholar 

  • Vermeulen A, Deslypere JP, Paridaens R, Leclercq G, Roy F, Heuson JC (1986) Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur J Cancer Clin Oncol 22:515–525

    Article  CAS  PubMed  Google Scholar 

  • Walker RA, Martin CV (2007) The aged breast. J Pathol 211:232–240

    Article  CAS  PubMed  Google Scholar 

  • Yaghjyan L, Colditz GA (2011) Estrogens in the breast tissue: a systematic review. Cancer Causes Control 22:529–540

    Article  PubMed  PubMed Central  Google Scholar 

  • Young J, Bulun SE, Agarwal V, Couzinet B, Mendelson CR, Simpson ER, Schaison G (1996) Aromatase expression in a feminizing adrenocortical tumor. J Clin Endocrinol Metab 81:3173–3176

    CAS  PubMed  Google Scholar 

  • Zhou J, Gurates B, Yang S, Sebastian S, Bulun SE (2001) Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by C/EBPbeta. Cancer Res 61:2328–2334

    CAS  PubMed  Google Scholar 

  • Zhu BT, Conney AH (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1–27

    Article  PubMed  Google Scholar 

Download references

Funding

This study has been supported by The Scientific Research Projects Coordination Unit of Istanbul Technical University (No 36004).

Author Contributions

This study was designed, directed, and coordinated by Mete Bora Tüzüner and Oğuz Öztürk. Oğuz Öztürk, as the principal investigator, provided conceptual and technical guidance for all aspects of the research. Hakan Bermek suggested and commented on the design of the experiments. Hande Turna contributed to patient selection and data collection. Tülin Öztürk, Şennur İlvan, and Zerrin Calay performed and analyzed immunohistochemistry experiments and also contributed to specimen selection. Allison Pınar Eronat and Fatih Seyhan performed RNA extractions and cDNA constructions from the tissue samples. Mete Bora Tüzüner planned and performed qRT-PCR studies and analyzed the data with Halil İbrahim Kısakesen and Hülya Yılmaz Aydoğan. The manuscript was written by Mete Bora Tüzüner and Oğuz Öztürk and commented on by all authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Oğuz Öztürk.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of this research.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tüzüner, M.B., Öztürk, T., Eronat, A.P. et al. Evaluation of Local CYP17A1 and CYP19A1 Expression Levels as Prognostic Factors in Postmenopausal Invasive Ductal Breast Cancer Cases. Biochem Genet 54, 784–802 (2016). https://doi.org/10.1007/s10528-016-9756-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10528-016-9756-7

Keywords

Navigation